C4 Therapeutics (CCCC) Receivables - Net: 2019-2025
Historic Receivables - Net for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to $6.5 million.
- C4 Therapeutics' Receivables - Net fell 36.74% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 36.74%. This contributed to the annual value of $3.1 million for FY2024, which is 73.71% down from last year.
- Per C4 Therapeutics' latest filing, its Receivables - Net stood at $6.5 million for Q3 2025, which was up 203.15% from $2.2 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Receivables - Net high stood at $13.6 million for Q1 2024, and its period low was $500,000 during Q3 2023.
- Its 3-year average for Receivables - Net is $5.3 million, with a median of $3.1 million in 2024.
- As far as peak fluctuations go, C4 Therapeutics' Receivables - Net tumbled by 74.23% in 2022, and later surged by 2,475.57% in 2024.
- Over the past 5 years, C4 Therapeutics' Receivables - Net (Quarterly) stood at $5.7 million in 2021, then plummeted by 74.23% to $1.5 million in 2022, then skyrocketed by 701.02% to $11.8 million in 2023, then crashed by 73.71% to $3.1 million in 2024, then tumbled by 36.74% to $6.5 million in 2025.
- Its Receivables - Net stands at $6.5 million for Q3 2025, versus $2.2 million for Q2 2025 and $8.0 million for Q1 2025.